Advanced mass spectrometry imaging for maize hybrid growth enhancement
Utilizing high-resolution mass spectrometry imaging, this research uncovers the unique metabolic signatures of maize hybrid meristems, identifying natural growth and stress response compounds without genetic modification. Potential applications include agricultural sustainability and biotechnology.
Overview
This innovative research employs advanced mass spectrometry imaging (MSI) to explore the unique metabolic signatures found in the meristems of maize hybrids. By mapping the metabolites that contribute to enhanced growth and stress response, this study identifies natural plant growth regulators that do not require genetic modification. This approach has already resulted in five patents and a licensed growth regulator, highlighting its potential impact on agricultural sustainability and biotechnology.
Technical specifications
- High-resolution mass spectrometry imaging (MSI): Utilizes MSI to create metabolic maps of maize meristems with 20-micron spatial resolution.
- Chemical imaging strategies: Identifies metabolites enriched in stem cell-enriched tissue, aiding in the discovery of growth-promoting and stress-resilient molecules.
- MALDI-MSI technology: Combines MS fingerprinting with high spatial resolution to explore chemical diversity in plant stem cells without genetic manipulation.
Technology readiness level
The technology is currently at TRL 4, having been validated in laboratory settings with ongoing efforts to translate findings for agricultural applications.
About University of California, San Diego
UC San Diego is a comprehensive public research university in La Jolla, anchored by an integrated academic health system. On the east campus, the 23‑acre Science Research Park co‑locates corporate R&D with university programs and connects to the health sciences district, enabling daily interaction among scientists, clinicians, and companies. The Jacobs School’s Corporate Affiliates Program provides structured engagement and recruiting, while the Office of Innovation & Commercialization supports IP, licensing, and startup formation. The research enterprise is sustained by competitive federal funding, with recent awards exceeding $1.7B annually. Established commercialization pathways streamline sponsored research and help partners move from proof of concept to deployment.
delivered to your inbox.